Global obesity spending reached nearly $24bn in 2023, an over sevenfold growth in value in just three years, driven by the advent of new agents, and from 2024 onwards the market is forecasted to accelerate rapidly, with a possible 24-27% CAGR to 2028, and a potential value of up to $131bn by 2028, according to the IQVIA Institutes Global Use of Medicines 2024 report 4
[DOI] [PubMed] [Google Scholar] 128.Chen F., Huang G
Figure 7.8 Diagrammatic representation of the action of a caustic chemical sclerosing solution on the vessel wall, showing formed elements of the blood
The results demonstrate that sperm viability and sperm count decrease and the sperm deformity rate increases as the altitude increases, and the effects are most obvious at an altitude of 6000 m
Conclusion A structured tapering plan is key to maintaining long-term weight management after stopping GLP-1 medications
97 , e0014423 (2023)